Turn Therapeutics Stock (NASDAQ:TTRX)


FinancialsChart

Previous Close

$3.50

52W Range

$2.57 - $26.50

50D Avg

$4.62

200D Avg

$4.62

Market Cap

$103.94M

Avg Vol (3M)

$692.12K

Beta

-

Div Yield

-

TTRX Company Profile


Global Health Solutions, Inc., doing business as Turn Therapeutics, operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. Global Health Solutions, Inc. was incorporated in 2015 and is based in Westlake Village, California.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

2

IPO Date

Oct 08, 2025

Website

TTRX Performance


TTRX Financial Summary


Dec 24Dec 23
Revenue--
Operating Income$-1.80M$-2.31M
Net Income$-1.77M$-2.29M
EBITDA$-1.75M$-2.26M
Basic EPS--
Diluted EPS--

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison


TickerCompany
IRDOpus Genetics, Inc.
IKTInhibikase Therapeutics, Inc.
ANIXAnixa Biosciences, Inc.
GLSIGreenwich LifeSciences, Inc.
TVGNTevogen Bio Holdings Inc.
AGENAgenus Inc.
SEERSeer, Inc.
HURATuHURA Biosciences, Inc.
VTGNVistaGen Therapeutics, Inc.
CGTXCognition Therapeutics, Inc.